These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Refractory Pure Red Cell Aplasia Manifesting as Deficiency of Adenosine Deaminase 2. Hashem H; Egler R; Dalal J J Pediatr Hematol Oncol; 2017 Jul; 39(5):e293-e296. PubMed ID: 28230570 [TBL] [Abstract][Full Text] [Related]
8. Development of EBV Related Diffuse Large B-cell Lymphoma in Deficiency of Adenosine Deaminase 2 with Uncontrolled EBV Infection. Gardner LS; Vaughan L; Avery DT; Meyts I; Ma CS; Tangye SG; Varikatt W; Lin MW J Clin Immunol; 2024 May; 44(5):118. PubMed ID: 38758417 [TBL] [Abstract][Full Text] [Related]
9. A misleading case of deficiency of adenosine deaminase 2 (DADA2): the magnifying glass of the scientific knowledge drives the tailored medicine in real life. Maccora I; Frongia I; Azzari C; Ricci S; Cimaz R; Simonini G Clin Exp Rheumatol; 2018; 36(6 Suppl 115):146. PubMed ID: 30148442 [No Abstract] [Full Text] [Related]
10. Warts and DADA2: a Mere Coincidence? Arts K; Bergerson JRE; Ombrello AK; Similuk M; Oler AJ; Agharahimi A; Mace EM; Hershfield M; Wouters C; De Somer L; Morren MA; Diego RP; Moens L; Freeman AF; Meyts I J Clin Immunol; 2018 Nov; 38(8):836-843. PubMed ID: 30386947 [No Abstract] [Full Text] [Related]
14. Deficiency of adenosine deaminase 2: a case series revealing clinical manifestations, genotypes and treatment outcomes from Turkey. Kisla Ekinci RM; Balci S; Hershfield M; Bisgin A; Dogruel D; Altintas DU; Yilmaz M Rheumatology (Oxford); 2020 Jan; 59(1):254-256. PubMed ID: 31292637 [No Abstract] [Full Text] [Related]
15. A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience. Rama M; Duflos C; Melki I; Bessis D; Bonhomme A; Martin H; Doummar D; Valence S; Rodriguez D; Carme E; Genevieve D; Heimdal K; Insalaco A; Franck N; Queyrel-Moranne V; Tieulie N; London J; Uettwiller F; Georgin-Lavialle S; Belot A; Koné-Paut I; Hentgen V; Boursier G; Touitou I; Sarrabay G Eur J Hum Genet; 2018 Jul; 26(7):960-971. PubMed ID: 29681619 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of deficiency of adenosine deaminase 2 caused by CECR1 mutation with myeloablative hematopoietic stem cell transplantation]. Song XC; Zhou F Zhonghua Er Ke Za Zhi; 2020 Jun; 58(6):509-511. PubMed ID: 32521966 [TBL] [Abstract][Full Text] [Related]
17. Disrupted N-linked glycosylation as a disease mechanism in deficiency of ADA2. Lee PY; Huang Y; Zhou Q; Schnappauf O; Hershfield MS; Li Y; Ganson NJ; Sampaio Moura N; Delmonte OM; Stone SS; Rivkin MJ; Pai SY; Lyons T; Sundel RP; Hsu VW; Notarangelo LD; Aksentijevich I; Nigrovic PA J Allergy Clin Immunol; 2018 Oct; 142(4):1363-1365.e8. PubMed ID: 29936104 [TBL] [Abstract][Full Text] [Related]
18. [Adenosine deaminase 2 deficiency: a disease with multiple presentations]. Caratsch L; Schnider C; Moi L; Theodoropoulou K; Candotti F; Hofer M Rev Med Suisse; 2022 Apr; 18(776):669-673. PubMed ID: 35385618 [TBL] [Abstract][Full Text] [Related]